GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mendus AB (OSTO:IMMU) » Definitions » Scaled Net Operating Assets

Mendus AB (OSTO:IMMU) Scaled Net Operating Assets : 0.79 (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Mendus AB Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Mendus AB's operating assets for the quarter that ended in Sep. 2024 was kr610.60 Mil. Mendus AB's operating liabilities for the quarter that ended in Sep. 2024 was kr21.77 Mil. Mendus AB's Total Assets for the quarter that ended in Jun. 2024 was kr740.96 Mil. Therefore, Mendus AB's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.79.


Mendus AB Scaled Net Operating Assets Historical Data

The historical data trend for Mendus AB's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mendus AB Scaled Net Operating Assets Chart

Mendus AB Annual Data
Trend Jun14 Jun15 Jun16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.91 13.55 0.74 0.76 0.98

Mendus AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.05 0.75 0.80 0.83 0.80

Competitive Comparison of Mendus AB's Scaled Net Operating Assets

For the Biotechnology subindustry, Mendus AB's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mendus AB's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mendus AB's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Mendus AB's Scaled Net Operating Assets falls into.



Mendus AB Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Mendus AB's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(635.17-26.737)/620.386
=0.98

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=755.952 - 120.782
=635.17

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=51.225 - 21.965 - 2.523
=26.737

Mendus AB's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(610.595-21.77)/740.961
=0.79

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=719.917 - 109.322
=610.595

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=44.226 - 19.788 - 2.668
=21.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mendus AB Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Mendus AB's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Mendus AB Business Description

Industry
Traded in Other Exchanges
Address
Vastra Tradgardsgatan 15, Stockholm, SWE, 11153
Mendus AB is a clinical-level biopharmaceutical company based on the company's allogeneic dendritic cell biology focused on the development of immunotherapies that address tumor recurrence and hard-to-treat established tumors. Its operations consist of research and development for pharmaceuticals.

Mendus AB Headlines

From GuruFocus

Immunomedics: A Solid Cancer Research Play

By Ishan Majumdar Ishan Majumdar 07-08-2020